Limited Source Blood Testing Reagents

The U.S. Army Medical Command’s Western Regional Contracting Office intends to award a firm fixed price contract valued at $150,000 to Immucor, Inc. for a one-year period. The procurement covers the supply of specialized blood testing reagents, including blood group typing reagents, rare blood antisera, quality control kits, and reaction kits specifically designed for use at Madigan Healthcare System, Fort Lewis, Washington. Immucor holds proprietary rights to these reagents used in conjunction with established laboratory testing protocols adhering to the facility’s standard operating procedures. This acquisition will follow the Simplified Acquisition Procedures under FAR Part 13 and is being conducted through a limited source selection pursuant to FAR Subpart 13.106-1(b)(1). The notice clarifies that it is not a request for proposals, and no solicitation will be issued; however, responses may be considered for future acquisitions. Interested parties may submit information exclusively via email to the designated purchasing agent, Walter J. Bischoff. The contract aims to support critical blood testing requirements at the healthcare system using authorized reagents with proprietary restrictions, ensuring compliance with federal procurement regulations.